Jeffrey S. Mathiesen's Insider Trades & SAST Disclosures
Jeffrey S. Mathiesen's most recent trade in NeuroOne Medical Technologies Corp was a trade of 27,778 Common Stock done . Disclosure was reported to the exchange on Feb. 14, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jeffrey S. Mathiesen.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| NeuroOne Medical Technolog... | Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 27,778 | 114,414 | - | 0 | Common Stock | |
| NeuroOne Medical Technolog... | Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2025 | 17,025 | 17,025 | - | - | Option to Purchase Common Stock | |
| Helius Medical Technologie... | Jeffrey S. Mathiesen | Director, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2025 | 139,857 | 139,857 | - | - | Stock Option (Right to Buy) | |
| Helius Medical Technologie... | Jeffrey S. Mathiesen | Director, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jul 2024 | 404,000 | 404,000 | - | - | Stock Option (Right to Buy) | |
| Panbela Therapeutics Inc. | Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 8,333 | 8,333 | - | - | Stock Option (right to buy) | |
| NeuroOne Medical Technolog... | Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 20,576 | 86,636 | - | 0 | Common Stock | |
| NeuroOne Medical Technolog... | Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 18,927 | 18,927 | - | - | Option to Purchase Common Stock | |
| Helius Medical Technologie... | Jeffrey S. Mathiesen | Director, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Feb 2023 | 2,693,000 | 2,693,000 | - | - | Stock Option (Right to Buy) | |
| Helius Medical Technologie... | Jeffrey S. Mathiesen | Director, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Sep 2022 | 18,000 | 18,000 | - | - | Stock Option (Right to Buy) | |
| NeuroOne Medical Technolog... | Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 29,240 | 66,060 | - | 0 | Common Stock | |
| NeuroOne Medical Technolog... | Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 29,230 | 29,230 | - | - | Option to Purchase Common Stock | |
| Helius Medical Technologie... | Jeffrey S. Mathiesen | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2022 | 37,000 | 37,000 | - | - | Stock Option (Right to Buy) | |
| Helius Medical Technologie... | Jeffrey S. Mathiesen | CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 8,011 | 11,948 (0%) | 0% | 0 | Class A Common Stock | |
| Helius Medical Technologie... | Jeffrey S. Mathiesen | CFO and Treasurer | Purchase of securities on an exchange or from another person at price $ 5.31 per share. | 17 Dec 2021 | 3,000 | 3,937 (0%) | 0% | 5.3 | 15,929 | Class A Common Stock |
| NeuroOne Medical Technolog... | Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 4,682 | 4,682 | - | - | Option to Purchase Common Stock | |
| NeuroOne Medical Technolog... | Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2021 | 4,592 | 36,811 | - | 0 | Common Stock | |
| Panbela Therapeutics Inc. | Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 12,368 | 12,368 | - | - | Stock Option (right to buy) | |
| Panbela Therapeutics Inc. | Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 4,316 | 10,191 (0%) | 0% | 0 | Common Stock | |
| Helius Medical Technologie... | Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 3,063 | 3,063 | - | - | Stock Option (Right to Buy) | |
| Helius Medical Technologie... | Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 937 | 937 (0%) | 0% | 0 | Class A Common Stock | |
| Panbela Therapeutics Inc. | Jeffrey S. Mathiesen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 2,875 | 5,875 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges